Calif. stem cell agency aims to bring therapies to trials

06/5/2009 | Bloomberg

The California Institute of Regenerative Medicine plans to provide about $20 million each to 10 or 12 research groups that hope to advance their stem cell treatments to human clinical trials within four years, said Alan Trounson, the agency's president. The agency also hopes to attract pharmaceutical firms that would invest in stem cell research, Trounson said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN